Oxford Drug Design
Oxford, United Kingdom
Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We are discovering new drugs with differentiated modes of action against challenging diseases with high unmet medical need. Based on a core competence platform in tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. Our differentiated drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates with highly innovative chemical scaffolds and modes of action against urgent pathogens.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2001
- Website
- oxforddrugdesign.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Oxford Drug Design?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now